Insulet to Present at Upcoming Investor Conferences
20 Agosto 2024 - 5:00AM
Business Wire
Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader
in tubeless insulin pump technology with its Omnipod® brand of
products, today announced that management will present at three
upcoming investor conferences (all Eastern Time):
- The 2024 Wells Fargo Healthcare Conference in Boston on
Wednesday, September 4, 2024 at 9:30 a.m.
- The Morgan Stanley 22nd Annual Global Healthcare Conference in
New York City on Friday, September 6, 2024 at 8:30 a.m.
- The Baird 2024 Global Healthcare Conference in New York City on
Tuesday, September 10, 2024 at 8:30 a.m.
To listen to the live audio webcasts of the presentations,
please visit investors.insulet.com/events. Replays of the webcasts
will also be available following the events.
About Insulet Corporation:
Insulet Corporation (NASDAQ: PODD), headquartered in
Massachusetts, is an innovative medical device company dedicated to
simplifying life for people with diabetes and other conditions
through its Omnipod product platform. The Omnipod Insulin
Management System provides a unique alternative to traditional
insulin delivery methods. With its simple, wearable design, the
tubeless disposable Pod provides up to three days of non-stop
insulin delivery, without the need to see or handle a needle.
Insulet’s flagship innovation, the Omnipod 5 Automated Insulin
Delivery System, is a tubeless automated insulin delivery system,
integrated with a continuous glucose monitor to manage blood sugar
with no multiple daily injections, zero fingersticks, and can be
fully controlled by a compatible personal smartphone in the U.S. or
by the Omnipod 5 Controller. Insulet also leverages the unique
design of its Pod by tailoring its Omnipod technology platform for
the delivery of non-insulin subcutaneous drugs across other
therapeutic areas. For more information, please visit insulet.com
and omnipod.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240815501629/en/
Investor Relations:
Deborah R. Gordon Vice President, Investor Relations (978)
600-7717 dgordon@insulet.com
Media:
Angela Geryak Wiczek Senior Director, Corporate Communications
(978) 932-0611 awiczek@insulet.com
Insulet (NASDAQ:PODD)
Gráfica de Acción Histórica
De Nov 2024 a Dic 2024
Insulet (NASDAQ:PODD)
Gráfica de Acción Histórica
De Dic 2023 a Dic 2024